Essential fatty acids in the treatment of dry eye

Ocular Surface

Volumn 8, Issue 1, 2010, Pages 18-28

  Rosenberg, Elena S ^a   Asbell, Penny A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Dry eye disease; Essential fatty acids; N 3; N 6; Omega 3; Omega 6; Polyunsaturated fatty acids

Indexed keywords

ALPHA TOCOPHEROL; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ESSENTIAL FATTY ACID; FISH OIL; GAMMA LINOLENIC ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PLACEBO;

BLEPHARITIS; CLINICAL TRIAL; DRUG EFFICACY; DRUG INHIBITION; DRUG SAFETY; DRY EYE; HEART INFARCTION; HUMAN; HYPERTRIGLYCERIDEMIA; KERATOCONJUNCTIVITIS; MEDICAL LITERATURE; METABOLISM; NONHUMAN; PROTEIN FUNCTION; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SJOEGREN SYNDROME; SUPPLEMENTATION;

EID: 77649196904     PISSN: 15420124     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-0124(12)70214-8     Document Type: Article

References (70)

1. Takahata K, Monobe K, Tada M, Weber PC. The benefits and risks of n-3 polyunsaturated fatty acids. Biosci Biotechnol Biochem 1998;62:2079-85
2. Harris WS, Miller M, Tighe AP, et al. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis 2008;197:12-24
3. Jump DB. The biochemistry of n-3 polyunsaturated fatty acids. J Biol Chem 2002;277:8755-8
4. Lewin GA, Schachter HM, Yuen D,et al. ECffects of omega-3 fatty acids on child and maternal health. Evid Rep TCechnol Assess (Summ) 2005;(118):1-11
5. Sadovsky R, Collins N, Tighe AP, et al. Dispelling the myths about omega-3 fatty acids. Postgrad Med 2008;120:92-100
6. Sayanova OV, Napier JA. Eicosapentaenoic acid: biosynthetic routes and the potential for synthesis in transgenic plants. Phytochemistry 2004;65:147-58
7. Parcell S. Biochemic and nutritional influences on pain, in: Audette EJ, Bailey a (eds). Integrative pain medicine: the science and practice of complementary and alternative medicine in pain management. new york,Springer Verlag, 2008
8. Das UN. Essential fatty acids and their metabolites could function as endogenous HMG-coa reductase and ace enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-in-flammatory, cytoprotective, and cardioprotective molecules. Lipids Health Dis 2008;7:37
9. Serhan CN. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol 2007;25:101-37
10. Serhan CN. Systems approach with inflammatory exudates uncovers novel anti-inflammatory and pro-resolving mediators. Prostaglandins Leukot Essent Fatty Acids 2008;79(3-5):157-63. epub 2008 nov 12.
11. Calder PC. n-3 fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin Sci 2004;107:1-11
12. Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother 2002;56:365-79
13. Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood) 2008;233:674-88
14. Calder PC. n-3 polyunsaturated fatty acids and cytokine production in health and disease. Ann Nutr Metab 1997;41:203-34
15. Kokke KH Morris JA Lawrenson JG. Oral omega-6 essential fatty acid treatment in contact lens associated dry eye. Cont Lens Anterior Eye 2008;31:141-6
16. Vassilopoulos D, Zurier RB, Rossetti RG, Tsokos GC. Gammalinolenic acid and dihomogammalinolenic acid suppress the CD3-mediated signal transduction pathway in human T cells. Clin Immunol Immunopathol 1997;83:237-44
17. Kris-Etherton P, Taylor D, Yu-Poth S, et al. Polyunsaturated fatty acids in the food chain in the united States. Am J Clin Nutr 2000;71(1 suppl):179S-188S
18. Harris WS. Fish oil supplementation: evidence for health benefits. Cleve Clin J Med 2004;71:208-21
19. Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 2006;296:1885-99
20. Kris-Etherton PM, Harris WS, Sppel LJ; American heart association, nutrition committee. fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002;106:2747-57
21. Mahaffey K. Fish and shellfish as dietary sources of methylmercury and the omega-3 fatty acids, eicosahexaenoic acid and docosahexaenoic acid: risks and benefits. Environ Res 2004;95:414-28
22. Jenkins DJ, Josse AR. Fish oil and omega-3 fatty acids. CMAJ 2008;178:150
23. Williams CM, Burdge G. Long-chain n-3 Pufa: plant v. marine sources. Proc Nutr Soc 2006;65:42-50
24. Harris WS, Mozaffarian D, Lefevre M, et al. Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. J Nutr 2009;139:804S-19S
25. Plourde M, Cunnane SC. Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements. Appl Physiol Nutr Metab 2007;32:619-34
26. Brown NA, Bron AJ, Harding JJ, Dewar HM. Nutrition supplements and the eye. Eye 1998;12( Pt 1):127-33
27. Chong EWT, Kreis AJ, Wong TY, et al. Dietary -3 fatty acid and fish intake in the primary prevention of age-related macular degeneration. a systematic review and meta-analysis. Arch Ophthalmol 2008;126:826-33
28. Hodge WG, Schachter HM, Barnes D, et al. Efficacy of omega-3 fatty acids in preventing age-related macular degeneration: a systematic review. Ophthalmology 2006;113:1165-72
29. Hodge W, Barnes D, Schachter HM, et al. Effects of omega-3 fatty acids on eye health. Evid Rep Technol Assess (Summ) 2005;(117):1-6
30. James MJ, Cleland LG. Dietary n-3 fatty acids and therapy for rheumatoid arthritis. Semin Arthritis Rheum 1997;27:85-97
31. Cleland LG, James MJ, Proudman SM. The role of fish oils in the treatment of rheumatoid arthritis. Drugs 2003;63:845-53 32. lecerf JM. fatty acids and cardiovascular disease. Nutr Rev 2009;67:273-83
32. Chan EJ, Cho L. What can we expect from omega-3 fatty acids? Cleve Clin J Med 2009;76:245-51
33. Riediger ND, Othman RA, Suh M, Moghadasian MH. A systematic review of the roles of n-3 fatty acids in health and disease. J Am Diet Assoc 2009;109:668-79
34. Galli C, Risé P. Fish consumption, omega 3 fatty acids and cardiovascular disease. The science and the clinical trials. Nutr Health 2009;20:11-20
35. Pauwels EK, Kostkiewicz M. Fatty acid facts, Part III: cardiovascular disease, or, a fish diet is not fishy. Drug News Perspect 2008;21:552-61
36. Harris WS, Kris-Etherton PM, Harris KA. Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults. Curr Atheroscler Rep 2008;10:503-9
37. Siscovick DS, Raghunathan TE, King I, , et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995;274:1363-7
38. Rissanen T, Voutilainen S, Nyyssönen K, et al. Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events: the Kuopio ischaemic heart disease risk factor study. Circulation 200028;102:2677-9
39. Dyerberg J, Bang HO, Stoffersen E, et al. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 1978 Jul 15;2(8081):117-9
40. Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DarT). Lancet 1989;2 (8666):757-61
41. (no authors listed). [Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin e after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.] Lancet 1999;354(9556):447-55
42. Yokoyama M, Origasa H, Matsuzaki M, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JelIS): a randomised open-label, blinded endpoint analysis. Lancet 2007;369(9567):1090-8
43. GISSI-HF Investigators, Tavazzi L, Maggioni AP, et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-hf trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008;372(9647):1223-30
44. http://www.cnpp.usda.gov/Publications/DietaryGuidelines/2010/ Meeting2/commentattachments/AHA-220b.pdf
45. Mueller BA, Talbert RL. Biological mechanisms and cardiovascular effects of omega-3 fatty acids. Clin Pharm 1988;7:795-807
46. Saynor R Verel D, Gillott T. The long-term effect of dietary supplementation with fish lipid concentrate on serum lipids, bleeding time, platelets and angina. Atherosclerosis 1984;50:3-10
47. Bender NK, Kraynak MA, Chiquette E, et alI. Effects of marine fish oils on the anticoagulation status of patients receiving chronic warfarin therapy. J Thromb Thrombolysis 1998;5:257-61
48. Bays HE. Safety considerations with omega-3 fatty acid therapy. Am J Cardiol 2007;99(6a):35c-43c
49. http://us.gsk.com/products/assets/us-lovaza.pdf
50. Harris WS. Expert opinion: omega-3 fatty acids and bleeding-cause for concern? Am J Cardiol 2007;99(6a):44c-46c
51. Puri BK. The safety of evening primrose oil in epilepsy. Prostaglandins Leukot Essent Fatty Acids 2007;77:101-3
52. Martinez M. Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr 1992;120:S129-38
53. Fliesler SJ, Anderson RE. Chemistry and metabolism of lipids in the vertebrate retina. Prog Lipid Res 1983;22:79-131
54. Hoffman DR, Boettcher JA, Diersen-Schade DA. Toward optimizing vision and cognition in term infants by dietary docosahexaenoic and arachidonic acid supplementation: a review of randomized controlled trials. Prostaglandins Leukot Essent Fatty Acids 2009;81:151-8
55. Tan JS, Wang JJ, Flood V, Mitchell P. Dietary fatty acids and the 10-year incidence of age-related macular degeneration: the Blue Mountains eye Study. Arch Ophthalmol 2009;127:656-65
56. Seddon JM, George S, Rosner B. Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the uS Twin Study of age-related Macular Degeneration. Arch Ophthalmol 2006;124:995-1001
57. Seddon JM, Rosner B, Sperduto RD, et al. Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol 2001;119:1191-9
58. Robman L, Vu H, Hodge A, et al. Dietary lutein, zeaxanthin, and fats and the progression of age-related macular degeneration. Can J Ophthalmol 2007;42:720-6
59. Hodge WG, Barnes D, Schachter HM, et al. Evidence for the effect of omega-3 fatty acids on progression of age-related macular degeneration: a systematic review. Retina 2007;27:216-21
60. http://www.areds2.org/
61. Tsubota K, Fujihara T, Saito K, Takeuchi T. Conjunctival epithelium expression of hla-Dr in dry eye patients. Ophthalmologica 1999;213:16-9
62. Pflugfelder SC, Jones D, Ji Z, et al. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca. Curr Eye Res 1999;19:201-11
63. (no authors listed). The definition and classification of dry eye disease: report of the Definition and classification Subcommittee of the International Dry eye WorkShop (2007).Ocul Surf 2007;5:75-92
64. Barabino S, Rolando M, Camicione P, et al. Systemic linoleic and gamma-linolenic acid therapy in dry eye syndrome with an inflammatory component. Cornea 2003;22:97-101
65. Aragona P, Bucolo C, Spinella R, et al. Systemic omega-6 essential fatty acid treatment and pge1 tear content in Sjögren's syndrome patients. Invest Ophthalmol Vis Sci 2005;46:4474-9
66. Macsai MS. The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an aOS thesis). Trans Am Ophthalmol Soc 2008;106:336-56
67. Creuzot C, Passemard M, Viau S,et al. [Improvement of dry eye symptoms with polyunsaturated fatty acids]. J Fr Ophtalmol 2006;29:868-73. In french.
68. Garcher CP, Brignole-Baudouin F, Baudouin C, et al. Influence of oral supplementation of omega-3 and omega-6 fatty acids on conjunctival inflammatory markers in dry eye patients (abstract). Invest Ophthalmol. Vis Sci 2009;50: arVO abstract 4638
69. Rashid S, Jin Y, Ecoiffier T, et al. Topical omega-3 and omega-6 fatty acids for treatment of dry eye. Arch Ophthalmol 2008;126:219-25
70. Miljanovic B, Trivedi KA, Dana MR, et al. Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. Am J Clin Nutr 2005;82:887-93